NCT03793426 - Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 28, 2021

Primary Completion Date

May 14, 2025

Study Completion Date

May 14, 2025

Conditions

Congenital Fibrinogen Deficiency

Interventions

BIOLOGICAL

Fibryga

Human plasma-derived fibrinogen concentrate

Trial Locations (4)

Fakultní nemocnice Ostrava, Ostrava

Gerinnungszentrum rhein-ruhr, Duisburg

Medizinische Klinik 2 / Institut für Transfusionsmedizin Universitätsklinikum, Frankfurt

Gerinnungszentrum Hochtaunus, Hamburg